EarningsQ2 2025 Earnings Report

Altimmune (ALT1) Q2 2025 Earnings Report

0 Followers

MX:ALT1 Q2 2025 EPS Results

Actual EPS-$4.68

Consensus EPS-$5.82

Beat/MissBeat by +$1.14

One Year Ago EPS-$6.07

Actual Revenue$86.66K

Expected Revenue$17.33K

Beat/MissBeat by +$69.32K

YoY Revenue Growth0.00%

QuarterQ2 2025

Date08/12/2025

TimeBefore Open

Conference CallTuesday, August 12, 2025

MX:ALT1 Upcoming Earnings

Altimmune's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:ALT1 Q2 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-2.31 / -	-3.64	―
Aug 12, 2026	2026 (Q2)	-2.39 / -2.08	-4.679	55.56% (+2.60)
May 13, 2026	2026 (Q1)	-4.19 / -3.12	-4.506	30.77% (+1.39)
Mar 05, 2026	2025 (Q4)	-4.12 / -4.68	-5.719	18.18% (+1.04)
Nov 06, 2025	2025 (Q3)	-4.71 / -3.64	-5.546	34.38% (+1.91)
Aug 12, 2025	2025 (Q2)	-5.82 / -4.68	-6.066	22.86% (+1.39)
May 13, 2025	2025 (Q1)	-6.10 / -4.51	-5.893	23.53% (+1.39)
Feb 27, 2025	2024 (Q4)	-5.75 / -5.72	-9.359	38.89% (+3.64)
Nov 12, 2024	2024 (Q3)	-6.19 / -5.55	-6.759	17.95% (+1.21)
Aug 08, 2024	2024 (Q2)	-6.05 / -6.07	-5.546	-9.37% (-0.52)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed